Citi Starts Dimension Therapeutics (DMTX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Goldman Sachs Starts Dimension Therapeutics (DMTX) at Buy
November 16, 2015 7:20 AM ESTGoldman Sachs initiated coverage on Dimension Therapeutics (NASDAQ: DMTX) with a Buy rating and a price target of $20.00.
For an analyst ratings summary and ratings history on Dimension Therapeutics click here. For more ratings news on Dimension Therapeutics click here.
Shares of Dimension Therapeutics closed at $13.88 yesterday.
... MoreCanaccord Genuity Starts Dimension Therapeutics (DMTX) at Buy
November 16, 2015 7:19 AM ESTCanaccord Genuity initiated coverage on Dimension Therapeutics (NASDAQ: DMTX) with a Buy rating and a price target of $20.00.
For an analyst ratings summary and ratings history on Dimension Therapeutics click here. For more ratings news on Dimension Therapeutics click here.
Shares of Dimension Therapeutics closed at $13.88 yesterday.
... More